Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Global Cord Blood Corporation

CO•NYSE
Healthcare
Medical - Diagnostics & Research
$2.99
$0.77(34.58%)
U.S. Market opens in 15h 52m

Global Cord Blood Corporation (CO) Stock Overview

Explore Global Cord Blood Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap400.1M
P/E Ratio5.01
EPS (TTM)$0.59
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$2.78

CO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Global Cord Blood Corporation (CO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.01 and a market capitalization of 400.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.08%
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
14.91%
3-Year Change
-9.19%
5-Year Change
-65.82%
All-Time (Max) Change
-45.14%

Contact Information

https://www.globalcordbloodcorp.com
852 3605 8180
Bank of China Tower, Central, NaN, NaN

Company Facts

12,020 Employees
IPO DateJan 25, 2007
CountryHK

Frequently Asked Questions